Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02392078 · ClinicalTrials.gov registry record
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
A clinical trial, sponsored by Monteris Medical.
- Completed
- Registry status
- 1,153
- Enrollment target
NCT02392078: Completed study, sponsored by Monteris Medical.
NCT02392078 is a clinical trial that has completed, run by Monteris Medical. The registered enrollment target is 1,153 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02392078 has completed, sponsored by Monteris Medical.
- COMPLETED
- Registry status
- 1,153 participants
- Enrollment target
Study Summary
The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 5 years to evaluate safety, QoL, and procedural outcomes including local control failure rate, progression free survival, overall survival, and seizure freedom in up to 3,000 patients and up to 50 sites.
Primary Outcome
Safety profile described by the NBS and surgical-related AEs
Interventions
- DEVICE NeuroBlate System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,153 participants |
| Start Date | 2015-10 |
| Est. Completion | 2023-09-30 |
What the finished NCT02392078 record still lists
NCT02392078 is an observational study that tracks outcomes without assigning an intervention. Its 1,153 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which NeuroBlate System is the first listed.
NCT02392078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02392078 about?
NCT02392078 is a clinical study titled "Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System". The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a p...
What is the current status of trial NCT02392078?
This trial is currently completed. The enrollment target is 1,153 participants. The study started on 2015-10. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT02392078?
The interventions under investigation include: NeuroBlate System (DEVICE).
Who is sponsoring clinical trial NCT02392078?
This trial is sponsored by Monteris Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474301 · 1,152 participants
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
- NCT05564026 · 1,151 participants
Molecular Epidemiology of Pediatric Germ Cell Tumors
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- NCT06528314 · 1,150 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia